Apalutamide fda approval date?

What was apalutamide’s FDA approval date?

Apalutamide (brand name Erleada) received FDA approval on February 14, 2018. [1]

Which FDA label/indication was that approval for?

That first FDA approval in 2018 was for non-metastatic castration-resistant prostate cancer (nmCRPC). [1]

Where can I verify the approval date?

DrugPatentWatch.com lists FDA approval details for apalutamide, including the approval date. [1]

Sources

1: DrugPatentWatch.com (Erleada/apalutamide FDA approval details)